Relationship Between Human Cytomegalovirus and IL-17A in Iraqi Women with Polycystic Ovary Syndrome

Zahraa Mushrq Hadi Khorsheed; Ifad Kerim Abd Al-shibly; Asmaa Kadhim Gatea

doi:10.54133/ajms.v6i2.939

المؤلفون

Zahraa Mushrq Hadi Khorsheed Department of Microbiology, College of Medicine, Babylon University, Hilla, Iraq https://orcid.org/0009-0005-5645-5770
Ifad Kerim Abd Al-shibly Department of Microbiology, College of Medicine, Babylon University, Hilla, Iraq
Asmaa Kadhim Gatea Department of Obstetrics and Gynecology, College of Medicine, Babylon University, Hilla, Iraq

DOI:

https://doi.org/10.54133/ajms.v6i2.939

الكلمات المفتاحية:

Human cytomegalovirus، Interleukin-17، Immunological regulator، Polycystic ovary syndrome

الملخص

Background: Evidence indicates a potential link between PCOS and low-grade infections. IL-17, also known as IL-17A, is an essential immunological regulator, especially in disorders such as polycystic ovarian syndrome (PCOS). The human cytomegalovirus is a β-herpesvirus that causes inflammation and remains dormant in the host for life. The cytomegalovirus has been central to several PCOS-related concepts. The role of IL-17A in CMV infection remains unknown. Objective: To establish the correlation between PCOS and CMV, as well as the connection between PCOS and serum levels of IL17A. Methods: A case-control study included 60 women with PCOS compared to 40 healthy controls. Samples were analyzed regarding CMV via the real-time PCR technique. Furthermore, the ELISA technique measured serum levels of the IL-17A cytokine. Every sample was taken between September 2023 and January 2024. Results: Positive results for CMV were seen in 50 (83.3%) of patients with PCOS compared with 10 (16.7%) who had negative results, while 6 (15.0%) of healthy control subjects had positive results and 34 (85.0%) had negative results; the difference was highly significant. Furthermore, women with polycystic ovary syndrome had a significantly higher IL-17A serum level when compared to healthy controls. Conclusions: In Iraqi women, HCMV infection in patients with PCOS can be considered a risk factor. Moreover, the results show that IL-17A is an excellent prognostic marker of polycystic ovary syndrome.

التنزيلات

بيانات التنزيل غير متوفرة بعد.

المراجع

Kiran GU, Vali DY, Shankar DY, Lokesh G, Chaitanya PK, Sujitha S. Overview of polycystic ovary syndrome (PCOS). World J Adv Engineer Technol Sci. 2023;8(2):011–22. doi: 10.30574/wjaets.2023.8.2.0052.

Deswal R, Narwal V, Dang A, Pundir CS. The prevalence of polycystic ovary syndrome: A brief systematic review. J Hum Reprod Sci. 2020;13(4):261-271. doi: 10.4103/jhrs.JHRS_95_18.

Yan D, Yan-Fang W, Shi-Yang Z, Rui-Lin M, Xue-Song D, Xiao M, et al. Is polycystic ovary syndrome appropriately diagnosed by obstetricians and gynaecologists across China: a nationwide survey. J Ovarian Res. 2021;14(1):25. doi: 10.1186/s13048-021-00780-6.

Rasquin LI, Anastasopoulou C, Mayrin JV, (Eds.), Polycystic Ovarian Disease. StatPearls Publishing, Treasure Island (FL); 2023. PMID: 29083730.

Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020;35:100937. doi: 10.1016/j.molmet.2020.01.001.

Rostamtabar M, Esmaeilzadeh S, Tourani M, Rahmani A, Baee M, Shirafkan F, et al. Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome. J Cell Physiol. 2021;236(2):824-838. doi: 10.1002/jcp.29912.

Özçaka Ö, Buduneli N, Ceyhan BO, Akcali A, Hannah V, Nile C, et al. Is interleukin-17 involved in the interaction between polycystic ovary syndrome and gingival inflammation? J Periodontol. 2013;84(12):1827–1837. doi: 10.1902/jop.2013.120483.

Foroozanfard F, Soleimani A, Arbab E, Samimi M, Tamadon MR. Relationship between IL-17 serum level and ambulatory blood pressure in women with polycystic ovary syndrome. J Nephropathol. 2017;6(1):15–24. doi: 10.15171/jnp.2017.04.

Kalyan S, Patel MS, Kingwell E, Côté HCF, Liu D, Prior JC. Competing factors link to bone health in polycystic ovary syndrome: Chronic low-grade inflammation takes a toll. Sci Rep. 2017;7(1):3432. doi: 10.1038/s41598-017-03685-x.

Mills KHG. IL-17 and IL-17-producing cells in protection versus pathology. Nat Rev Immunol. 2023;23(1):38-54. doi: 10.1038/s41577-022-00746-9.

Payne S, (Ed.) Viruses: from understanding to investigation, (2nd Ed.), Elsevier; 2022.

Al Mana H, Yassine HM, Younes NN, Al-Mohannadi A, Al-Sadeq DW, Alhababi D, et al. The current status of cytomegalovirus (CMV) prevalence in the MENA region: A systematic review. Pathogens. 2019;8(4). doi: 10.3390/pathogens8040213.

Fulkerson HL, Nogalski MT, Collins-McMillen D, Yurochko AD. Overview of Human Cytomegalovirus Pathogenesis. In: Yurochko AD, (ed.), Human Cytomegaloviruses: Methods and Protocols. New York: Springer US; 2021:1–18. doi: 10.1007/978-1-0716-1111-1_1.

Alabassi HM, Kadri ZHM, Mahmood MM, AL-Kubisi MI. The possible etiological role of CMV and EBV latent infections in polycystic ovary syndrome Iraqi patients. Syst Rev Pharmacy. 2020;11(7):51–53. doi:10.31838/srp.2020.7.08.

Zhou H, Xu J, Hong L, Jia Y, Burk LV, Chi F, et al. The alterations of circulating mucosal-associated invariant T cells in polycystic ovary syndrome. Front Endocrinol (Lausanne). 2022;13:1038184. doi: 10.3389/fendo.2022.1038184.

Vasyukova E, Zaikova E, Kalinina O, Gorelova I, Pyanova I, Bogatyreva E, et al. Inflammatory and anti-inflammatory parameters in PCOS patients depending on body mass index: A case-control study. Biomedicines. 2023;11(10). doi: 10.3390/biomedicines11102791.

Kuang H, Duan Y, Li D, Xu Y, Ai W, Li W, et al. The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome. PLoS One. 2020;15(8):e0235404. doi: 10.1371/journal.pone.0235404.

Zafari Zangeneh F, Naghizadeh MM, Masoumi M. Polycystic ovary syndrome and circulating inflammatory markers. Int J Reprod Biomed. 2017;15(6):375-382. PMID: 29177240.

Abraham Gnanadass S, Divakar Prabhu Y, Valsala Gopalakrishnan A. Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Archives of Gynecology and Obstetrics. 2021;303(3):631–43.

Zhai Y, Pang Y. Systemic and ovarian inflammation in women with polycystic ovary syndrome. J Reprod Immunol. 2022;151:103628. doi: 10.1016/j.jri.2022.103628.

Ma WT, Yao XT, Peng Q, Chen DK. The protective and pathogenic roles of IL-17 in viral infections: friend or foe? Open Biol. 2019 ;9(7):190109. doi: 10.1098/rsob.190109.

Sahu U, Biswas D, Prajapati VK, Singh AK, Samant M, Khare P. Interleukin-17-A multifaceted cytokine in viral infections. J Cell Physiol. 2021;236(12):8000-8019. doi: 10.1002/jcp.30471.

Liu LL, Li XF, Qin WQ, Liu XL, Li G, Shu SN, et al. Is IL-17 an accomplice contributing to salivary gland damage during CMV infection? Future Virol. 2013;8(9):861–869. doi: 10.2217/fvl.13.78.

Dhital R, Anand S, Zeng Q, Velazquez VM, Boddeda SR, Fitch JR, et al. Th1/17 cells infiltrate murine cytomegalovirus-infected renal allografts via virus-induced CCL20 and promote Th1 cells through IL-17A. bioRxiv. 2021;2021.08.05.455061. doi: 10.1101/2021.08.05.455061.

García-Torre A, Bueno-García E, López-Martínez R, Rioseras B, Díaz-Molina B, Lambert JL, et al. CMV infection is directly related to the inflammatory status in chronic heart failure patients. Front Immunol. 2021; 12:687582. doi: 10.3389/fimmu.2021.687582.